1765. STDs in the Biomedical HIV Prevention (or PrEP) Era
Session: Symposium: HIV Prevention: PrEP and Beyond
Saturday, October 29, 2016: 11:30 AM
Room: La Nouvelle Orleans Ballroom
Stephanie Cohen, MD, MPH, University of California, San Francisco, San Francisco, CA


S. Cohen, Gilead: Investigator , Gilead provided study drug and paid for drug level testing in the US PrEP demo project; I was a protocol co-chair and site co-PI of this study

See more of: HIV Prevention: PrEP and Beyond
See more of: Symposium
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.